oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Second European multi-disciplinary conference of national strategies for Chlamydia trach. and human papillomavirus NSCP conf. in Berlin, 2013 enhanced detection, management and surveillance of sexually transmitted infections in Europe are essential!
Univ Latvia, LV-1005 Riga, Latvia..
Univ Florence, Florence, Italy..
Cty Hosp Halland, Halmstad, Sweden..
London Sch Hyg & Trop Med, London WC1, England..
Show others and affiliations
2013 (English)In: International journal of immunopathology and pharmacology, ISSN 0394-6320, Vol. 26, no 4, 839-845 p.Article in journal, Editorial material (Refereed) Published
Abstract [en]

There is a need for updated guidance on detection, management and surveillance of sexually transmitted infections (STIs). Chlamydia, gonorrhoea and syphilis reporting needs to be mandatory in more European countries to aid collection of data. More widespread Chlamydia screening is needed in many countries as this is the only way to reduce complications. The role of Human Papillomavirus (HPV) screening in a situation where the prevalence of HPV infection has dropped significantly was also discussed in the context of the high cost of screening, the need for a relatively complex infrastructure, particularly in developing countries, and falling vaccination costs. An integrated HPV vaccination and screening policy could be the most appropriate with vaccination at 9-13 years as recommended by WHO and a single HPV screen at 35-39 years, possibly repeated thereafter every 10 years. Female and male HPV vaccination programmes could lead to near elimination of genital warts in both females and males. Surveillance of STIs should be intensified where needed; additional or better quality data should be collected including reasons for testing, denominator data to estimate positivity rates, diagnostic methods, concurrent STIs, sexual orientation and country of acquisition; more analytical rather than descriptive epidemiology is needed.

Place, publisher, year, edition, pages
2013. Vol. 26, no 4, 839-845 p.
Keyword [en]
Chlamydia trachomatis, HPV, STI, surveillance, diagnostics, vaccine, conference
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-56676ISI: 000329892900001PubMedID: 24355218OAI: oai:DiVA.org:oru-56676DiVA: diva2:1083574
Available from: 2017-03-21 Created: 2017-03-21 Last updated: 2017-03-21Bibliographically approved

Open Access in DiVA

No full text

PubMed

Search in DiVA

By author/editor
Unemo, Magnus
By organisation
Orebro University Hospital
In the same journal
International journal of immunopathology and pharmacology
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 2 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf